HKEX Stock Code: 01093English|繁體|简体

Highlight - 2024 1Q

Revenue
RMB8,983M, +11.5%
Underlying profit attributable to shareholders
RMB1,724M, +11.6%
Reported profit attributable to shareholders
RMB1,613M, +12.9%
Basic earnings per share (reported)
RMB13.61 cents, +13.5%
Basic earnings per share (underlying profit)
RMB14.55 cents, +12.3%

Key Products

Finished drugs
Bulk drugs
© Copyright 2024 CSPC Pharmaceutical Group Limited. All Rights Reserved.